when were glp 1 drugs approved What to Make of the GLP-1 Coverage and Cost Landscape Weight-loss drugs such as Ozempic
Description
GLP-1 RA cardiovascular outcome trials in patients with T2D reported a neutral impact of the drugs on HF hospitalisation
In the same FDA drug safety communication, post-marketing cases of urosepsis and pyelonephritis were discussed, leading to the addition of warnings of severe infections to the prescribing information for these products
[DOI] [PubMed] [Google Scholar] 39.Garber A, Henry RR, Ratner R, Hale P, Chang CT, Bode B
Think of it this way
Accumulating evidence demonstrates that GLP-1RAs exert heterogeneous effects across different tumor types (Table 1)
Differences also exist within drug classes
